BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Immunology Podcast
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250225
DTEND;VALUE=DATE:20250226
DTSTAMP:20260413T093830
CREATED:20250206T234436Z
LAST-MODIFIED:20250225T214930Z
UID:6023-1740441600-1740527999@www.immunologypodcast.com
SUMMARY:Dr. Luke O'Neill
DESCRIPTION:Dr. Luke O’Neill is a Professor and Chair of Biochemistry at Trinity College Dublin. His research group is focused on the molecular basis of inflammation\, with a particular emphasis on innate immunity and immunometabolism. They and other groups have shown that several metabolites\, such as succinate\, itaconate\, and fumarate\, and enzymes\, such as PKM2 and GAPDH play specific roles in the immune response in macrophages. They endeavor to provide a better understanding into the metabolic regulation of immune cell function and the innate immune system\, with the aim of developing novel therapies to treat inflammatory diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-luke-oneill
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/02/Luke-ONeill-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250129
DTSTAMP:20260413T093830
CREATED:20240903T233235Z
LAST-MODIFIED:20250122T202050Z
UID:5883-1738022400-1738108799@www.immunologypodcast.com
SUMMARY:Dr. Erica Saphire
DESCRIPTION:Dr. Erica Saphire is a Professor\, President & Chief Executive Officer at La Jolla Institute for Immunology. Her research explains\, at the molecular level\, how and why viruses are pathogenic and provides the roadmap for medical defense. Her team has solved the structures of the Ebola\, Sudan\, Marburg\, Bundibugyo and Lassa virus glycoproteins\, explained how they remodel these structures as they drive themselves into cells\, how their proteins suppress immune function and where human antibodies can defeat these viruses.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-erica-saphire
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/09/Erica-Saphire-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241203
DTEND;VALUE=DATE:20241204
DTSTAMP:20260413T093830
CREATED:20241127T193039Z
LAST-MODIFIED:20241216T231955Z
UID:5970-1733184000-1733270399@www.immunologypodcast.com
SUMMARY:Dr. Lili Yang
DESCRIPTION:Dr. Lili Yang is a Professor of Microbiology\, Immunology\, and Molecular Genetics at the University of California\, Los Angeles. Her research centers on deciphering the molecular mechanisms regulating anti-cancer immune responses\, exploiting knowledge to develop novel immunotherapies for treating cancer\, and translating these new cancer immunotherapies from bench to bedside. Their research also extends to studying immune regulation of other chronic diseases including infections\, allergies\, and autoimmune diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-lili-yang
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/11/zLiliYang-Portrait-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241119
DTEND;VALUE=DATE:20241120
DTSTAMP:20260413T093830
CREATED:20241104T075642Z
LAST-MODIFIED:20241104T075642Z
UID:5952-1731974400-1732060799@www.immunologypodcast.com
SUMMARY:Dr. Rahul Roychoudhuri
DESCRIPTION:Dr. Rahul Roychoudhuri is a Professor of Professor of Cancer Immunology at the University of Cambridge. His research aims to uncover the molecular and cellular mechanisms underpinning immune regulation and cancer immunosuppression. They study how T cell immunity is suppressed in cancer and Treg development and function.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-rahul-roychoudhuri
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/11/Rahul-Roychoudhuri-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241105
DTEND;VALUE=DATE:20241106
DTSTAMP:20260413T093830
CREATED:20241024T184722Z
LAST-MODIFIED:20241118T181323Z
UID:5935-1730764800-1730851199@www.immunologypodcast.com
SUMMARY:Dr. Pascal Meier
DESCRIPTION:Dr. Pascal Meier is a Professor and Group Leader at the Institute of Cancer Research. His group investigates the complex relationship between cell death\, immunity and tumorigenesis. Particularly\, they focus on the role of cell death and inflammation in adaptation to tissue stress\, treatment resistance\, and tumor surveillance. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-pascal-meier
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/10/Pascal-Meier-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241022
DTEND;VALUE=DATE:20241023
DTSTAMP:20260413T093830
CREATED:20241021T005347Z
LAST-MODIFIED:20241021T005347Z
UID:5926-1729555200-1729641599@www.immunologypodcast.com
SUMMARY:Drs. Joanne Flynn and Stephen Hedrick
DESCRIPTION:Dr. JoAnne Flynn is a Professor of Microbiology & Molecular Genetics at the University of Pittsburgh. Dr. Flynn’s career has been largely focused on the immunology of tuberculosis (TB). She identified several immune factors that were involved in controlling TB and was the President of the American Association of Immunologists (AAI) from 2018-2019. \nDr. Stephen Hedrick is Chancellor’s Associates Chair VII and Distinguished Professor Emeritus at the University of California San Diego.  Dr. Hedrick is a Distinguished Fellow of AAI and was the recipient of the AAI Distinguished Service Award in 1997. He has a strong track record of eloquently advocating for childhood vaccination.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-joanne-flynn-and-stephen-hedrick
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/10/JoAnne-and-Stephen-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241008
DTEND;VALUE=DATE:20241009
DTSTAMP:20260413T093830
CREATED:20240905T185823Z
LAST-MODIFIED:20241018T181113Z
UID:5886-1728345600-1728431999@www.immunologypodcast.com
SUMMARY:Dr. Theresa Alenghat
DESCRIPTION:Dr. Theresa Alenghat is a Professor in the Immunobiology Division and Margaret K. Hostetter Chair at Cincinnati Children’s Hospital Medical Center\, University of Cincinnati. Her lab investigates mechanisms underlying the host-microbiota relationship\, and how this regulation affects intestinal immunity and inflammatory bowel disease. Dr. Alenghat has led studies revealing that epigenetics and histone deacetylases permit intestinal epithelial cells to sense commensal bacteria and convey this information to the mammalian host. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-theresa-alenghat
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/Theresa-Alenghat-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240925
DTSTAMP:20260413T093830
CREATED:20240821T230644Z
LAST-MODIFIED:20241008T204514Z
UID:5863-1727136000-1727222399@www.immunologypodcast.com
SUMMARY:Dr. Roslyn Kemp
DESCRIPTION:Dr. Roslyn Kemp is a Professor of Immunology at the University of Otago. Dr. Kemp’s research focuses on T cells as mediators of anti-tumour immunity and inflammation. Specifically\, they study the role of inflammation and the unique features of different subsets of T cells and myeloid cells\, focusing on cancer and gut-specific immune responses; and how these cell subsets are involved in patient outcomes. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-roslyn-kemp
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/Roslyn-Kemp-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240827
DTEND;VALUE=DATE:20240828
DTSTAMP:20260413T093830
CREATED:20240822T042356Z
LAST-MODIFIED:20240827T173454Z
UID:5866-1724716800-1724803199@www.immunologypodcast.com
SUMMARY:Dr. Kipp Weiskopf
DESCRIPTION:Dr. Kipp Weiskopf is a Valhalla Fellow at the Whitehead Institute. Dr. Weiskopf’s lab studies novel macrophage and myeloid immune checkpoints. Weiskopf began studying the CD47/SIRP⍺ interaction as a graduate student and demonstrated that CD47-blocking therapies could unleash immune attack against cancer and enhance a number of existing therapies. He also showed they could be used to treat small cell lung cancer and might permit bone marrow transplantation without using chemotherapy or radiation. The Weiskopf lab studies additional mechanisms that control myeloid cell activation in tumors to develop new treatments for cancer and other life-threatening diseases\, such as COVID-19.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kipp-weiskopf
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/08/kipp-weiskopf-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240813
DTEND;VALUE=DATE:20240814
DTSTAMP:20260413T093830
CREATED:20240731T163455Z
LAST-MODIFIED:20240815T173703Z
UID:5838-1723507200-1723593599@www.immunologypodcast.com
SUMMARY:Dr. Adrian Erlebacher
DESCRIPTION:Dr. Adrian Erlebacher is a Professor in the Department of Laboratory Medicine at the University of California San Francisco. His research lies at the intersection of immunology and developmental biology. In particular\, his lab is interested in how the developmental properties of a tissue influence its ability to mount a successful immune response\, and\, conversely\, how cells of the immune system influence tissue development and remodeling. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-adrian-erlebacher
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/07/Adrian-Erlebacher-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240730
DTEND;VALUE=DATE:20240731
DTSTAMP:20260413T093830
CREATED:20240605T203758Z
LAST-MODIFIED:20240731T163531Z
UID:5782-1722297600-1722383999@www.immunologypodcast.com
SUMMARY:Dr. Jeffrey Rathmell
DESCRIPTION:Dr. Jeffrey Rathmell is the Molecular Pathology and Immunology Associate Director\, Cornelius Vanderbilt Professor of Immunobiology\, and Director of the Vanderbilt Center for Immunobiology at Vanderbilt University Medical Center. Dr. Rathmell studies mechanisms by which extracellular cues influence lymphocyte death and differentiation in efforts to control inflammatory diseases and leukemia. Their work is highly interdisciplinary and collaborative involving the fields of immunology\, cancer biology\, and cell metabolism. They use genetic and biochemical approaches with a goal to understand and exploit the specific metabolic programs of each cell type or activation state and selectively modulate effector lymphocytes in inflammatory diseases and cancer. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jeffrey-rathmell
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/06/Jeffrey-Rathmell-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240702
DTEND;VALUE=DATE:20240703
DTSTAMP:20260413T093830
CREATED:20240403T184217Z
LAST-MODIFIED:20240702T224429Z
UID:5648-1719878400-1719964799@www.immunologypodcast.com
SUMMARY:Dr. Susan Kaech
DESCRIPTION:Dr. Susan Kaech is Professor and Director of the NOMIS Center for Immunobiology and Microbial Pathogenesis at the Salk Institute. She aims to understand how memory T cells are produced during infection and vaccination\, how they function and why they can fail to induce long-term immunity\, particularly during chronic disease or cancer. Her lab has been a leader in using genetic and molecular tools to identify the genes and signaling molecules involved in generating two specific types of memory T cells\, CD4 and CD8\, from precursor cells during both acute and chronic viral infections. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-susan-kaech
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/04/Susan-Kaech-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240611
DTEND;VALUE=DATE:20240612
DTSTAMP:20260413T093830
CREATED:20240605T202629Z
LAST-MODIFIED:20240605T202629Z
UID:5779-1718064000-1718150399@www.immunologypodcast.com
SUMMARY:Dr. Erika Moore
DESCRIPTION:Dr. Erika Moore is an Assistant Professor at the University of Maryland\, where she her lab is steadfastly committed to engineering biomaterial models that harness the regenerative potential of the immune system\, particularly addressing health disparities. Ongoing research at the Moore Lab encompasses a wide spectrum\, ranging from modeling vasculitis in lupus to investigating age-related macrophage function\, decoding extracellular matrix signaling’s impact on macrophage activity\, and examining ancestral influences on innate immune responses.\n \n 
URL:https://www.immunologypodcast.com/upcoming-guests/dr-erika-moore
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/06/Erika-Moore-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240604
DTEND;VALUE=DATE:20240605
DTSTAMP:20260413T093830
CREATED:20240529T205211Z
LAST-MODIFIED:20240529T205211Z
UID:5766-1717459200-1717545599@www.immunologypodcast.com
SUMMARY:Dr. Kellen Cavagnero
DESCRIPTION:Dr. Kellen Cavagnero is a Postdoctoral Fellow at the University of California\, San Diego. Throughout his career\, Kellen’s research has focused on defining the events that occur after initial exposure to an inflammatory stimulus. His work aims to understand how fibroblasts—a cell type thought to be immunologically inert—contribute to chronic inflammatory conditions and defense against pathogens. His podcast\, Inflammatory Content\, aims to make science and the stories of the people behind the science accessible to everyone.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kellen-cavagnero
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/05/thumbnail_Kellen-Cavagnero-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240504T123000
DTEND;TZID=America/New_York:20240504T140000
DTSTAMP:20260413T093830
CREATED:20240327T160048Z
LAST-MODIFIED:20240617T211109Z
UID:5625-1714825800-1714831200@www.immunologypodcast.com
SUMMARY:The Immunology Podcast Presents: Artificial Intelligence and Immunology
DESCRIPTION:Join the Immunology Podcast for a live show at IMMUNOLOGY2024™! Brenda and Jason will chat with Drs. Jo Viney and Ryan Peckner from Seismic Therapeutic about how artificial intelligence is being used in immunology research. They will discuss how AI is contributing to innovations in the field\, including the use of machine learning in drug development. \nDate: May 4\, 2024\nTime: 12:30 – 2:00 p.m. EDT\nLocation: McCormick Place Convention Center\, Room W180 \nGuests:\nJo Viney\, PhD\nCEO\, President\, Co-Founder\, Seismic Therapeutic\nRyan Peckner\, PhD\nDirector of Machine Learning and Computational Biology\, Seismic Therapeutic\n\n\nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/the-immunology-podcast-presents-artificial-intelligence-and-immunology
LOCATION:McCormick Place Convention Center\, 2301 S Martin Luther King Dr\, Chicago\, IL\, 60616\, United States
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Jo-and-Ryan-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240423
DTEND;VALUE=DATE:20240424
DTSTAMP:20260413T093830
CREATED:20240325T171649Z
LAST-MODIFIED:20240427T064005Z
UID:5629-1713830400-1713916799@www.immunologypodcast.com
SUMMARY:Dr. Caleb Lareau
DESCRIPTION:Dr. Caleb Lareau is an Assistant Professor at Memorial Sloan Kettering Cancer Center. His team of interdisciplinary scientists specializes in computational and translational immunology. Specifically\, they develop and utilize single-cell multi-omics technologies and computational biology to study human hematopoietic system as how immune cells change as we age and are exposed to pathogens\, including endemic viruses. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-caleb-lareau
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Caleb-Lareau-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240409
DTEND;VALUE=DATE:20240410
DTSTAMP:20260413T093830
CREATED:20240315T222703Z
LAST-MODIFIED:20240427T065232Z
UID:5618-1712620800-1712707199@www.immunologypodcast.com
SUMMARY:Dr. Mitchell Kronenberg
DESCRIPTION:Dr. Mitchell Kronenberg is a Professor and President Emeritus at La Jolla Institute for Immunology. He and his team study study innate-like T lymphocytes\, including natural killer T cells\,  mucosal-associated invariant T cells\, and gd T cells\, as well as innate lymphoid cells. They are also interested in mucosal immunology and the development of inflammatory bowel diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-mitchell-kronenberg
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Mitch-Kronenberg.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240327
DTSTAMP:20260413T093830
CREATED:20240315T222114Z
LAST-MODIFIED:20240315T222141Z
UID:5614-1711411200-1711497599@www.immunologypodcast.com
SUMMARY:Dr. Scott Canna
DESCRIPTION:Dr. Scott Canna is an  Associate Professor of Pediatrics (Rheumatology) and Attending Physician\, Pediatric Rheumatology and Immune Dysregulation at the Children’s Hospital of Philadelphia. Dr. Canna’s group studies the intersections of hyper- and auto-inflammation. In particular\, they study two related disorders\, Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome\, because they typify the concept of hyperinflammation. They combine clinical insights from rheumatology and innate immunity with basic models of overwhelming systemic inflammation to define new disease subtypes and disease activity biomarkers\, to flesh out mechanisms of inflammatory disease\, and to test promising therapeutic strategies.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-scott-canna
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/03/Scott-Canna-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240313
DTSTAMP:20260413T093830
CREATED:20240208T185231Z
LAST-MODIFIED:20240208T185231Z
UID:5563-1710201600-1710287999@www.immunologypodcast.com
SUMMARY:Dr. Neelika Malavige
DESCRIPTION:Dr. Neelika Malavige is a well-recognized leader in the field of dengue. She is the Head of Dengue Global Programme and Scientific Affairs at DNDi. She is also a Professor at the University of Sri Jayewardenepura. She previously was Head of the Department of Immunology and Molecular Medicine\, where her research focus on dengue was to find out the therapeutic targets\, notably mediators of vascular leak\, the role of antibodies in disease pathogenesis\, and correlates of protection in dengue.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-neelika-malavige
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/02/Neelika-420px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240227
DTEND;VALUE=DATE:20240228
DTSTAMP:20260413T093830
CREATED:20240131T181450Z
LAST-MODIFIED:20240228T024043Z
UID:5548-1708992000-1709078399@www.immunologypodcast.com
SUMMARY:Dr. James Allison
DESCRIPTION:Dr. James Allison is Regental Professor and Chair of the Department of Immunology\, the Olga Keith Wiess Distinguished University Chair for Cancer Research\, Director of the Parker Institute for Cancer Research\, Executive Director of the Immunotherapy Platform\, and Director of the James P. Allison Institute at MD Anderson Cancer Center. He has spent a distinguished career studying the regulation of T cell responses and developing strategies for cancer immunotherapy. He earned the 2018 Nobel Prize in Physiology or Medicine\, which he shared with Dr. Tasuku Honjo\, “for their discovery of cancer therapy by inhibition of negative immune regulation.” \nAmong his most notable discoveries are the determination of the T cell receptor structure and that CD28 is the major costimulatory molecule that allows full activation of naïve T cells and prevents anergy in T cell clones. His lab resolved a major controversy by demonstrating that CTLA-4 inhibits T-cell activation by opposing CD28-mediated costimulation and that blockade of CTLA-4 could enhance T cell responses\, leading to tumor rejection in animal models. This finding and a great deal of persistence paved the way for the field of immune checkpoint blockade therapy for cancer. \nWork in his lab led to the development of ipilimumab\, an antibody to human CTLA-4 and the first immune checkpoint blockade therapy approved by the FDA. Among many honors\, he is a member of the National Academies of Science and Medicine and received the Lasker-Debakey Clinical Medical Research award in 2015. His current work seeks to improve immune checkpoint blockade therapies currently used by our clinicians and identify new targets to unleash the immune system in order to eradicate cancer. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-james-allison
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/01/James-Allison-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240213
DTEND;VALUE=DATE:20240214
DTSTAMP:20260413T093830
CREATED:20240207T170631Z
LAST-MODIFIED:20240207T170631Z
UID:5555-1707782400-1707868799@www.immunologypodcast.com
SUMMARY:Dr. Akiko Iwasaki\, Francisco Gomez-Rivera\, and Dr. Jason Augustine
DESCRIPTION:  \nDr. Akiko Iwasaki is the Sterling Professor of Immunobiology and Molecular\, Cellular\, and Developmental Biology at Yale University. Francisco Gomez-Rivera is an Immunology Program Graduate Student Candidate at the University of Michigan. Dr. Jason Augustine has retired recently from his position as a Research Microbiologist/Immunologist at the US Environmental Protection Agency. \nThis episode will focus on the upcoming IMMUNOLOGY2024 meeting taking place in Chicago\, May 3-7.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-akiko-iwasaki-francisco-gomez-rivera-and-dr-jason-augustine
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/02/IMMUNOLOGY2024.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240130
DTEND;VALUE=DATE:20240131
DTSTAMP:20260413T093830
CREATED:20240110T171504Z
LAST-MODIFIED:20240208T183629Z
UID:5515-1706572800-1706659199@www.immunologypodcast.com
SUMMARY:Dr. Dionna Williams
DESCRIPTION:Dr. Dionna Williams is an Assistant Professor of Molecular and Comparative Pathobiology at Johns Hopkins School of Medicine. Their research interests are in the neuropathogenesis of HIV\, regulatory mechanisms of neuroimmune signaling\, drug delivery to the central nervous system\, and immunologic and pharmacologic contributors to health disparities. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-dionna-williams
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2024/01/Dionna-Williams-420px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240116
DTEND;VALUE=DATE:20240117
DTSTAMP:20260413T093830
CREATED:20240112T214632Z
LAST-MODIFIED:20240119T201836Z
UID:5521-1705363200-1705449599@www.immunologypodcast.com
SUMMARY:Drs. Akiko Iwasaki and Aimee Bernard
DESCRIPTION:Dr. Akiko Iwasaki is the Sterling Professor of Immunobiology and Molecular\, Cellular\, and Developmental Biology at Yale University. Her research focuses on the mechanisms of immune defense against viruses at the mucosal surfaces\, and the development of mucosal vaccine strategies. She is active on social media and works to combat mis- and disinformation surrounding science. \nDr. Aimee Bernard is an Assistant Professor of Immunology and Microbiology at the University of Colorado. As a faculty mentor\, she guides a group of volunteer graduate students from all across campus to run a non-profit\, after-school science program – Think Like a Scientist. In her role as the Executive Director of the Human Immunology and Immunotherapy Initiative (HI3) Aimee coordinates the development of the research and clinical infrastructure necessary to create an all-inclusive\, premier facility for the discovery and use of human immunotherapies for the treatment of cancer and autoimmune diseases. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/drs-akiko-iwasaki-and-aimee-bernard
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2024/01/Akiko-and-Aimee-update-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231107
DTEND;VALUE=DATE:20231108
DTSTAMP:20260413T093830
CREATED:20231029T190558Z
LAST-MODIFIED:20231029T190610Z
UID:5426-1699315200-1699401599@www.immunologypodcast.com
SUMMARY:Dr. Sophia Liu
DESCRIPTION:Dr. Sophia Liu is a Core Faculty Member and Early Independence Fellow at the Ragon Institute of Mass General\, MIT\, and Harvard. She enjoys creating new ways to measure temporally and spatially dynamic cell interactions and is particularly interested in studying T and B-cell development. Her lab’s research focuses on immune cell interactions in tissues and dynamics across immune development and aging.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-sophia-liu
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/10/Sophia-Liu-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231010
DTEND;VALUE=DATE:20231011
DTSTAMP:20260413T093830
CREATED:20230915T061846Z
LAST-MODIFIED:20230915T062011Z
UID:5388-1696896000-1696982399@www.immunologypodcast.com
SUMMARY:Dr. Peter Fecci
DESCRIPTION:Dr. Peter Fecci is a Professor of Neurosurgery and the Director of the Center for Brain and Spine Metastasis at Duke University. His research centers around brain tumor immunology and immunotherapy\, and T cell dysfunction in glioblastoma and other intracranial cancers.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-peter-fecci
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/09/Peter-Fecci-square-crop.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230912
DTEND;VALUE=DATE:20230913
DTSTAMP:20260413T093830
CREATED:20230815T054339Z
LAST-MODIFIED:20230815T055823Z
UID:5327-1694476800-1694563199@www.immunologypodcast.com
SUMMARY:Dr. Kristin Anderson
DESCRIPTION:Dr. Kristin Anderson is an Assistant Professor at the University of Virginia. Her research program develops engineered T cell immunotherapies\, integrating cellular and molecular techniques with in vivo mouse models and in vitro patient-based models of solid tumors to study the complex interactions between antitumor T cells and the tumor microenvironment.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-kristin-anderson
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Kristin-Anderson-420px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230829
DTEND;VALUE=DATE:20230830
DTSTAMP:20260413T093831
CREATED:20230823T222314Z
LAST-MODIFIED:20230823T222358Z
UID:5339-1693267200-1693353599@www.immunologypodcast.com
SUMMARY:Dr. Vinod Balachandran
DESCRIPTION:Dr. Vinod Balachandran is an Attending Surgeon at Memorial Sloan Kettering Cancer Center and a Member of the David. M Rubenstein Center for Pancreatic Cancer Research. His lab aims to discover new ways to stimulate the immune system to treat cancer through careful study of rare cancer patients with exceptional outcomes. They specifically focus on a rare subgroup of pancreatic cancer patients with exceptional long-term survival to discover new immunotherapeutic approaches.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-vinod-balachandran
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Vinod-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230815
DTEND;VALUE=DATE:20230816
DTSTAMP:20260413T093831
CREATED:20230811T204809Z
LAST-MODIFIED:20230823T175156Z
UID:5320-1692057600-1692143999@www.immunologypodcast.com
SUMMARY:Dr. Greg Delgoffe
DESCRIPTION:Dr. Greg Delgoffe is an Associate Professor at the University of Pittsburgh. The Delgoffe lab studies the intersection of metabolism and immunity in cancer. Specifically\, they investigate how tumor cells deplete their local microenvironment of nutrients\, effectively starving tumor-infiltrating T cells and preventing their function. \nListen to the episode here.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-greg-delgoffe
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2023/08/Greg-Delgoffe-420-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230801
DTEND;VALUE=DATE:20230802
DTSTAMP:20260413T093831
CREATED:20230713T221747Z
LAST-MODIFIED:20230713T221818Z
UID:5302-1690848000-1690934399@www.immunologypodcast.com
SUMMARY:Dr. Daniel Streicker
DESCRIPTION:Dr. Daniel Streicker is a Professor of Viral Ecology at the University of Glasgow. His lab uses a range of approaches to identify patterns in pathogen transmission between species\, and develop solutions for real-world disease problems. Current projects are investigating transmissible and transferrable vaccines for disease control in bats\, prediction of the host tropism of viruses from their genome sequences\, understanding how satellite viruses jump between host species\, and forecasting vampire bat rabies outbreaks in humans and livestock.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-daniel-streicker
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/07/Daniel-Streicker-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230718
DTEND;VALUE=DATE:20230719
DTSTAMP:20260413T093831
CREATED:20230712T233406Z
LAST-MODIFIED:20230712T233419Z
UID:5294-1689638400-1689724799@www.immunologypodcast.com
SUMMARY:Dr. Jamie Spangler
DESCRIPTION:Dr. Jamie Spangler is an Assistant Professor in the Departments of Biomedical and Chemical & Biomolecular Engineering at Johns Hopkins University. Her group aims to redesign existing proteins and engineer new proteins that overcome these limitations. Combining cutting-edge technologies from structural biophysics\, molecular engineering\, and translational immunology\, they create new platforms for the development of targeted therapeutics to treat a broad range of immune diseases.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-jamie-spangler
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2023/07/Jamie-Spangler-square-420-px.jpg
END:VEVENT
END:VCALENDAR